Phosphoinositide 3-kinase inhibitors for inhibiting...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/41 (2006.01) A61K 31/517 (2006.01) A61K 31/52 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2598409

The invention relates generally to phosphoinositide 3-kinases (PI3Ks) , and more particularly to methods of inhibiting leukocyte accumulation comprising selectively inhibiting phosphoinositide 3-kinase delta (PI3K.delta.) and phosphoinositide 3-kinase gamma (PI3K.gamma.) activities in endothelial cells. The disclosed methods may be used to treat individuals having an inflammatory condition where leukocytes are found to be accumulating at the site of insult or inflamed tissue. The inflammatory condition may be attributed to or associated with an underlying disorder not typically associated with inflammation, e.g. cancer, coronary vascular disease, etc.

D'une manière générale, la présente invention a trait à des phosphoinositide 3-kinases (PI3Ks), et plus particulièrement à des procédés d'inhibition d'accumulation de leucocytes comprenant l'inhibition sélective des activités de 3-kinase delta (PI3Kd) et phosphoinositide 3-kinase gamma (PI3K?) dans des cellule endothéliales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phosphoinositide 3-kinase inhibitors for inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphoinositide 3-kinase inhibitors for inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoinositide 3-kinase inhibitors for inhibiting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1866886

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.